Lu Wei-Hua, Jin Xiao-Ju, Jiang Xiao-Gan, Wang Zhen, Wu Jing-Yi, Shen Guang-Gui
Department of Anesthesiology and Critical Care Medicine, Yijishan Hospital, Wannan Medical College, Wuhu, China.
Indian J Pharmacol. 2015 Jan-Feb;47(1):49-54. doi: 10.4103/0253-7613.150333.
Improvement of mucosal barrier function and reduction of bacterial translocation are important in the management of sepsis. The mechanisms that underlie the protective effects of colloids on the intestinal mucosal barrier are unclear. The study aims to investigate the effect of fluid resuscitation with hydroxyethyl starch (HES) 130/0.4 against intestinal mucosal barrier dysfunction in a rabbit model of sepsis.
Thirty healthy rabbits were randomly and equally divided into a sham-operated control, a sepsis model, or a sepsis + HES treatment group. The sepsis model and sepsis + HES treatment groups were subjected to a modified colon ascendens stent peritonitis (CASP) procedure to induce sepsis. Four hours after the CASP procedure, fluid resuscitation was performed with 6% HES 130/0.4. Arterial and superior mesenteric vein blood samples were collected 4 and 8 h after the CASP procedure for blood gas analysis and measuring tumor necrosis factor-α, interleukin-10, and D-lactate levels. The rabbits were euthanized 8 h after CASP, and sections of the small intestine were stained to evaluate histopathological changes.
Respiratory rate and blood pressure were stable during the resuscitation period. Fluid resuscitation with 6% HES 130/0.4 alleviated pathological changes in the abdominal cavity, improved blood gas parameters and inflammatory mediator levels, decreased plasma D-lactate levels, and reduced intestinal mucosal injury compared with the non-treated sepsis model.
Fluid resuscitation with 6% HES 130/0.4 protects against intestinal mucosal barrier dysfunction in rabbits with sepsis, possibly via mechanisms associated with improving intestinal oxygen metabolism and reducing the release of inflammatory mediators.
改善黏膜屏障功能和减少细菌移位在脓毒症的治疗中至关重要。胶体对肠黏膜屏障的保护作用机制尚不清楚。本研究旨在探讨用130/0.4羟乙基淀粉(HES)进行液体复苏对脓毒症兔模型肠黏膜屏障功能障碍的影响。
30只健康兔随机等分为假手术对照组、脓毒症模型组或脓毒症+HES治疗组。脓毒症模型组和脓毒症+HES治疗组采用改良升结肠支架腹膜炎(CASP)手术诱导脓毒症。CASP手术后4小时,用6% HES 130/0.4进行液体复苏。在CASP手术后4小时和8小时采集动脉血和肠系膜上静脉血样本进行血气分析,并测定肿瘤坏死因子-α、白细胞介素-10和D-乳酸水平。CASP手术后8小时对兔实施安乐死,取小肠切片进行组织病理学变化评估。
复苏期间呼吸频率和血压稳定。与未治疗的脓毒症模型相比,用6% HES 130/0.4进行液体复苏可减轻腹腔病理变化,改善血气参数和炎症介质水平,降低血浆D-乳酸水平,并减轻肠黏膜损伤。
用6% HES 130/0.4进行液体复苏可保护脓毒症兔的肠黏膜屏障功能,可能是通过改善肠道氧代谢和减少炎症介质释放相关的机制实现的。